Featured
-
-
Article |
YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation
- Ming Zhang
- , Jue Wang
- & Changyan Ma
-
Article
| Open AccessNon-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer
- Ashwin Sachdeva
- , Claire A. Hart
- & Noel Clarke
-
Review Article
| Open AccessRecent insights into the effects of metabolism on breast cancer cell dormancy
- Sara Bartlome
- & Catherine Cecilia Berry
-
Review Article |
Bone marrow niches in the regulation of bone metastasis
- Fenfang Chen
- , Yujiao Han
- & Yibin Kang
-
Review Article
| Open AccessEndocytosis: a pivotal pathway for regulating metastasis
- Imran Khan
- & Patricia S. Steeg
-
Article
| Open AccessNotch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry
- Mattia Capulli
- , Dayana Hristova
- & Anna Teti
-
Article
| Open AccessPrognostic value of serum alkaline phosphatase in spinal metastatic disease
- Aditya V. Karhade
- , Quirina C. B. S. Thio
- & Joseph H. Schwab
-
Article
| Open AccessCirculating tumour cells and their association with bone metastases in patients with neuroendocrine tumours
- Francesca M. Rizzo
- , Clare Vesely
- & Tim Meyer
-
Molecular Diagnostics
| Open AccessThe TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone
- Yuhu Dai
- , Dong Ren
- & Xinsheng Peng
-
Molecular Diagnostics
| Open AccessTumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer
- S R Rao
- , A E Snaith
- & C M Edwards
-
Short Communication
| Open AccessIncorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer
- David Thurtle
- , Ray C J Hsu
- & Tristan Barrett
-
Clinical Study
| Open AccessComparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients
- O A Catalano
- , E Nicolai
- & M Salvatore
-
Molecular Diagnostics
| Open AccessArachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer
- M Brown
- , J-A Roulson
- & N W Clarke
-
Molecular Diagnostics
| Open AccessProstate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction
- G T Lee
- , D I Kang
- & I Y Kim
-
Translational Therapeutics
| Open AccessHuman fucosyltransferase 6 enables prostate cancer metastasis to bone
- J Li
- , A D Guillebon
- & M R King
-
Molecular Diagnostics
| Open AccessBiochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
- A Alcaraz
- , R González-López
- & J Bellmunt
-
Molecular Diagnostics
| Open AccessPrimary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature
- L D′Amico
- , S Patanè
- & I Roato
-
Molecular Diagnostics
| Open AccessUsefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
- C de la Piedra
- , A Alcaraz
- & J Morote
-
Clinical Study
| Open AccessConcomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
- B Beuselinck
- , P Wolter
- & P Schöffski
-
Molecular Diagnostics
| Open AccessResponse in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials
- A Som
- , S-M Tu
- & P G Corn
-
Molecular Diagnostics
| Open AccessClinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases
- S Akiyoshi
- , T Fukagawa
- & M Mori
-
Clinical Study
| Open AccessEffect of Paget’s disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis
- S-M Tu
- , A Som
- & S-CJ Yeung
-
Translational Therapeutics
| Open AccessTargeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo
- B Gibert
- , B Eckel
- & C Diaz-Latoud
-
Mini Review
| Open AccessNotch signalling in cancer progression and bone metastasis
- N Sethi
- & Y Kang
-
Clinical Study
| Open AccessDocetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study
- R Petrioli
- , A Pascucci
- & G Francini
-
Molecular Diagnostics
| Open AccessEnhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
- A Shiirevnyamba
- , T Takahashi
- & H Uehara
-
Letter to the Editor
| Open AccessAssessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria
- V Vassiliou
- & D Andreopoulos
-
Clinical Study
| Open AccessTumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer
- T Hamaoka
- , C M Costelloe
- & N T Ueno